• LAST PRICE
    0.4910
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.4600/ 3
  • Ask / Lots
    0.5600/ 3
  • Open / Previous Close
    0.0000 / 0.4910
  • Day Range
    ---
  • 52 Week Range
    Low 0.4677
    High 26.4100
  • Volume
    1,545
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.499
TimeVolumePRFX
09:32 ET2230.494
09:39 ET2000.4805
09:43 ET1150.4805
09:48 ET33580.5113
10:01 ET11980.477
10:06 ET5870.477
10:08 ET2140.4677
10:10 ET70080.49
10:12 ET60000.5005
10:14 ET289200.49565
10:15 ET11500.4951
10:17 ET1870.4951
10:19 ET1000.486
10:33 ET164420.477097
10:35 ET17000.4706
10:50 ET48300.5
10:51 ET13000.5
10:55 ET549970.5045
10:57 ET10000.5008
11:04 ET117560.5008
11:26 ET11970.509
11:33 ET2250.509
12:18 ET22950.5014
12:21 ET3000.5095
12:30 ET3000.491
12:45 ET239120.493901
12:50 ET2000.481
12:57 ET15500.505
01:10 ET1500.507
01:33 ET41980.5099
01:46 ET150450.5
01:48 ET1970.507362
02:56 ET7130.51
03:27 ET3000.51
03:32 ET3000.51
03:38 ET20000.491
03:48 ET34250.4929
03:59 ET9000.491
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRFX
PainReform Ltd
1.2M
-0.1x
---
United StatesNUNZ
Nunzia Pharmaceutical Corp
1.3M
0.0x
---
United StatesNXEN
Nexien Biopharma Inc
1.4M
-5.4x
---
United StatesLSDI
Lucy Scientific Discovery Inc
1.3M
-0.1x
---
United StatesENMI
DH Enchantment Inc
1.2M
-10.8x
---
United StatesCNNA
Cann American Corp
1.6M
0.0x
---
As of 2024-06-20

Company Information

PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

Contact Information

Headquarters
65 Yigal Alon St.TEL AVIV-YAFO, Israel 6744316
Phone
---
Fax
---

Executives

Chairman of the Board
Ehud Geller
Chief Executive Officer, Chief Financial Officer
Ilan Hadar
Chief Operating Officer
Sigal Aviel
Chief Technology Officer, Director
Eli Hazum
Vice President - Pharmaceutical Operations
Rita Keynan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.2M
Revenue (TTM)
$0.00
Shares Outstanding
2.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.60
EPS
$-7.77
Book Value
$4.19
P/E Ratio
-0.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.